LORI LANG: Open Payments
NPI 1841808839 · DANBURY, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$386 in 3 payments from 3 companies in 2025. Trend: 2023 $19 · 2024 $144 · 2025 $386
Food & beverage: $386
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 1 | $140 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $124 |
| Alkermes, Inc. | 1 | $122 |
Products named: INGREZZA, CAPLYTA, VIVITROL.
Industry payments across CT — which companies pay providers there.
